Search Results - "Journal of rheumatology"

Refine Results
  1. 1
  2. 2

    Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample by Singh, Jasvinder A, Yu, Shaohua, Chen, Lang, Cleveland, John D

    Published in Journal of rheumatology (01-09-2019)
    “…To project future total hip and knee joint arthroplasty (THA, TKA) use in the United States to 2040. We used the 2000-2014 US National Inpatient Sample (NIS)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment by Smolen, Josef S, Genovese, Mark C, Takeuchi, Tsutomu, Hyslop, David L, Macias, William L, Rooney, Terence, Chen, Lei, Dickson, Christina L, Riddle Camp, Jennifer, Cardillo, Tracy E, Ishii, Taeko, Winthrop, Kevin L

    Published in Journal of rheumatology (01-01-2019)
    “…Baricitinib is an oral, once-daily selective Janus kinase (JAK1/JAK2) inhibitor for adults with moderately to severely active rheumatoid arthritis (RA). We…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality by Raimundo, Karina, Solomon, Joshua J, Olson, Amy L, Kong, Amanda M, Cole, Ashley L, Fischer, Aryeh, Swigris, Jeffrey J

    Published in Journal of rheumatology (01-04-2019)
    “…Interstitial lung disease (ILD) is commonly associated with rheumatoid arthritis (RA) and can have significant morbidity and mortality. The objective of this…”
    Get full text
    Journal Article
  9. 9

    Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years by van Vollenhoven, Ronald F, Fleischmann, Roy M, Furst, Daniel E, Lacey, Stuart, Lehane, Patricia B

    Published in Journal of rheumatology (01-10-2015)
    “…Final evaluation of the longterm safety of rituximab (RTX) in rheumatoid arthritis (RA) up to 11 years. Pooled observed case analysis of data from patients…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive by Orlowsky, Eric W, Kraus, Virginia Byers

    Published in Journal of rheumatology (01-03-2015)
    “…Although osteoarthritis (OA) has existed since the dawn of humanity, its pathogenesis remains poorly understood. OA is no longer considered a "wear and tear"…”
    Get full text
    Journal Article
  17. 17

    GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting by Coates, Laura C, Corp, Nadia, van der Windt, Danielle A, Soriano, Enrique R, Kavanaugh, Arthur

    Published in Journal of rheumatology (15-02-2021)
    “…Throughout 2020, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) has been working to update the GRAPPA treatment…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence by Durcan, Laura, Clarke, William A, Magder, Laurence S, Petri, Michelle

    Published in Journal of rheumatology (01-11-2015)
    “…Hydroxychloroquine (HCQ) is used for its effect on systemic lupus erythematosus (SLE) disease activity and longterm benefits. This can be limited by adherence…”
    Get full text
    Journal Article
  20. 20